NasdaqGM:SPRYBiotechs
What ARS Pharmaceuticals (SPRY)'s neffyinSchools California Expansion Means For Shareholders
ARS Pharmaceuticals recently expanded its neffyinSchools program to California, allowing K–12 schools to request free neffy epinephrine nasal spray for emergency use, bringing the initiative to 24 states and over 8,000 participating schools with nearly 45,000 doses donated so far.
This move highlights how evolving school health policies and growing acceptance of needle-free anaphylaxis treatments can influence demand patterns and brand positioning for neffy in the education sector.
We’ll now...